DE69230643D1 - METHOD FOR TREATING VIRAL INFECTIONS - Google Patents

METHOD FOR TREATING VIRAL INFECTIONS

Info

Publication number
DE69230643D1
DE69230643D1 DE69230643T DE69230643T DE69230643D1 DE 69230643 D1 DE69230643 D1 DE 69230643D1 DE 69230643 T DE69230643 T DE 69230643T DE 69230643 T DE69230643 T DE 69230643T DE 69230643 D1 DE69230643 D1 DE 69230643D1
Authority
DE
Germany
Prior art keywords
crp
modified
virus
viral infections
treating viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230643T
Other languages
German (de)
Other versions
DE69230643T2 (en
Inventor
A Potempa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immtech International Inc
Original Assignee
Immtech International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immtech International Inc filed Critical Immtech International Inc
Publication of DE69230643D1 publication Critical patent/DE69230643D1/en
Application granted granted Critical
Publication of DE69230643T2 publication Critical patent/DE69230643T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention provides a method of treating a viral infection in a mammal comprising administering an effective amount of modified C-reactive protein (CRP) to the mammal. In particular, modified-CRP has been found to be effective and safe for treating retroviral infections, including human immunodeficiency virus 1. The invention also provides a method of neutralizing a virus comprising contacting the virus with modified-CRP. In particular, modified-CRP can be used to neutralize viruses in blood which is to be used for transfusions by adding the modified-CRP to the blood prior to the transfusion.
DE69230643T 1991-11-27 1992-11-23 METHOD FOR TREATING VIRAL INFECTIONS Expired - Fee Related DE69230643T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79944891A 1991-11-27 1991-11-27
PCT/US1992/010126 WO1993010799A1 (en) 1991-11-27 1992-11-23 Method of treating viral infections

Publications (2)

Publication Number Publication Date
DE69230643D1 true DE69230643D1 (en) 2000-03-09
DE69230643T2 DE69230643T2 (en) 2000-06-21

Family

ID=25175937

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230643T Expired - Fee Related DE69230643T2 (en) 1991-11-27 1992-11-23 METHOD FOR TREATING VIRAL INFECTIONS

Country Status (8)

Country Link
US (1) US5585349A (en)
EP (1) EP0616535B1 (en)
JP (1) JP3457309B2 (en)
AT (1) ATE189394T1 (en)
AU (1) AU662787B2 (en)
CA (1) CA2123786C (en)
DE (1) DE69230643T2 (en)
WO (1) WO1993010799A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874238A (en) * 1993-02-26 1999-02-23 Immtech International Inc. Mutant protein and methods and materials for making and using it
US6239099B1 (en) 1991-11-27 2001-05-29 Immtech International, Inc. Methods of treating viral infections
US6703219B1 (en) 1993-02-26 2004-03-09 Immtech International Inc. Mutant protein and methods and materials for making and using it
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein
DK0915707T3 (en) * 1996-01-25 2003-03-03 Profylakse Aps Pharmaceutical compositions comprising serum amyloid P component for prophylactic or therapeutic treatment of viral infections and kits for detecting the binding of compositions to viral components
US5850333A (en) * 1997-03-19 1998-12-15 Ingersoll-Rand Company Enclosure for machine control panel
US6331403B1 (en) * 1998-08-19 2001-12-18 Lawrence A. Potempa Use of mCRP to slow cell growth and to promote maturation of cells
US6190670B1 (en) * 1999-04-12 2001-02-20 Immtech International Inc. Use of mCRP to enhance immune responses
WO2005058359A2 (en) * 2003-12-15 2005-06-30 Theralogic Gmbh & Co. Kg Method for neutralizing effects of crp for increasing immune reactions to hiv
JP5959440B2 (en) 2010-01-19 2016-08-02 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Modified opsonin for pathogen detection and treatment
CA3149018A1 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3010522B1 (en) 2013-05-21 2021-01-20 President and Fellows of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (en) 2013-12-18 2021-07-07 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68925899T2 (en) * 1988-04-04 1996-10-02 Lawrence A Potempa BINDING IMMUNE COMPLEXES BY MODIFIED FORMS OF C-REACTIVE PROTEINS
DD294568A5 (en) * 1989-07-14 1991-10-02 Humboldt-Universitaet,Direkt. F. Forsch.,De METHOD FOR DETERMINING C REACTIVE PROTEIN
NL9100434A (en) * 1991-03-11 1992-10-01 Rijksuniversiteit PHARMACEUTICAL PREPARATIONS FOR THE FIGHT AGAINST VIRAL INFECTIONS AND IMMUNE DEFICIENCY DISEASES, PREPARATION AND USE THEREOF.
EP0586573B1 (en) * 1991-05-16 2001-12-19 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein

Also Published As

Publication number Publication date
CA2123786A1 (en) 1993-06-10
AU3146893A (en) 1993-06-28
JPH07501544A (en) 1995-02-16
EP0616535A4 (en) 1995-07-12
AU662787B2 (en) 1995-09-14
EP0616535B1 (en) 2000-02-02
JP3457309B2 (en) 2003-10-14
EP0616535A1 (en) 1994-09-28
DE69230643T2 (en) 2000-06-21
US5585349A (en) 1996-12-17
CA2123786C (en) 2000-08-01
WO1993010799A1 (en) 1993-06-10
ATE189394T1 (en) 2000-02-15

Similar Documents

Publication Publication Date Title
DE69230643D1 (en) METHOD FOR TREATING VIRAL INFECTIONS
ATE138575T1 (en) METHOD FOR INACTIVATION OF VIRUSES IN PHARMACEUTICAL COMPOSITIONS CONTAMINATED WITH VIRUSES
DE3684363D1 (en) PHOSPHONYLMETHOXYALKYL ADENINE FOR THE TREATMENT OF VIRUS DISEASES.
ATE108068T1 (en) ANTIBODY HETEROCONJUGATES FOR KILLING HIV-INFECTED CELLS.
DE69535758D1 (en) LIPID ANALOGUE FOR THE TREATMENT OF VIRAL INFECTIONS
DE69718612D1 (en) METHOD FOR THE PRESERVATION OF INFECTIOUS RECOMBINATING VIRUSES, VIRAL AQUEOUS SUSPENSION AND THEIR MEDICAL USE
ATE54828T1 (en) TREATMENT OF BIOLOGICAL AND PHARMACEUTICAL PRODUCTS ADOPTED ON A SOLID PHASE WITH VIRAL AND PYROGENIC INACTIVATING AGENTS.
ATE74282T1 (en) METHOD OF TREATMENT OF PLASMA AND ITS PRODUCTS.
ATE116637T1 (en) SULFONIC STILBEN DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES.
ATE165345T1 (en) SULFONIC ACID DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES
DE68906735D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING VIRUS DISEASES WITH LIVER EXTRACT.
ATE136468T1 (en) VACCINE FOR TREATING HSV
EA199800526A1 (en) DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF VIRAL INFECTIONS
DK0653939T3 (en) Use of a Hymenoptera Poison for the Preparation of a Drug for the Treatment of DNA Virus Infections
ES2066753T3 (en) USE OF A PREPARATION, CONTAINING IMMUNOGLOBULIN, FOR THE PROPHYLAXIS AND THERAPY OF AIDS, IN PEOPLE.
ES2162862T3 (en) USE OF TIMOSINE TO TREAT HEPATITIS C IN PATIENTS WHO DO NOT RESPOND TO THE INTERFER TREATMENT.
ATE155795T1 (en) USE OF LEUKOREGULIN FOR THE TREATMENT OF ANIMAL INFECTED WITH AN ENVELOPE VIRUS
DK135588A (en) INACTIVATION OF HIV IN PROTEINAL SOLUTIONS USING PHENOLES
ATE255417T1 (en) USE OF BRADYKININ ANTAGONISTS TO TREAT VIRUS DISEASES
DE69210737D1 (en) Use of L-2-oxothiazolidine-4-carboxylates for the manufacture of a medicament for the treatment of latent HIV infections
MX9400210A (en) TREATMENT OF VIRAL INFECTIONS.
ES2128322T3 (en) PEPTIDES THAT BLOCK INFECTIONS DUE TO HUMAN IMMUNODEFICIENCY VIRUSES AND PROCEDURES FOR THE USE OF THESE PEPTIDES.
ATE100318T1 (en) USE OF QUINOLYL AND ISOQUINOLYLOXAZOLE-2-ONES IN THE MANUFACTURE OF A MEDICATION FOR PREVENTING THE TRANSPORTABILITY OF GLYCOPROTEIN ENVELOPED VIRUSES.
ATE76302T1 (en) USE OF AN IMMUNOSTIMULANT BIOLOGIST SUBSTANCE IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF HUMAN IMMUNE DEFICIENCY VIRUS.
RU94038588A (en) Method of secondary immunodeficiency treatment

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee